Sureau, Léa http://orcid.org/0000-0002-5451-3464
Orvain, Corentin
Ianotto, Jean-Christophe http://orcid.org/0000-0001-9074-7287
Ugo, Valérie
Kiladjian, Jean-Jacques
Luque Paz, Damien http://orcid.org/0000-0002-4523-675X
Riou, Jérémie http://orcid.org/0000-0002-7056-9257
Article History
Received: 26 May 2021
Revised: 7 July 2021
Accepted: 8 July 2021
First Online: 27 July 2021
Competing interests
: CO has received consultancy fees from Novartis. JJK has been part of advisory boards for Novartis, Celgene, and CTI biopharma. The remaining authors declare no competing interests.